{"id":"NCT00231153","sponsor":"Cadence Pharmaceuticals","briefTitle":"Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous Catheters","officialTitle":"A Phase 3, Multicenter, Randomized, Evaluation Committee-Blinded Study to Assess the Efficacy of Topical Omiganan 1% Gel in Preventing Local Catheter Site Infections/Colonization in Patients Undergoing Central Venous Catheterization","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-08","primaryCompletion":"2008-06","completion":"2008-07","firstPosted":"2005-10-04","resultsPosted":"2009-08-13","lastUpdate":"2009-08-13"},"enrollment":1859,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Infection"],"interventions":[{"type":"DRUG","name":"Omiganan 1% gel","otherNames":[]},{"type":"DRUG","name":"Povidone-Iodine 10%","otherNames":[]}],"arms":[{"label":"Povidone-Iodine 10%","type":"ACTIVE_COMPARATOR"},{"label":"omiganan 1% gel","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine whether treatment with topical omiganan is more effective than treatment with topical povidone-iodine in preventing local catheter site infections and catheter colonization in patients who have central venous catheters.","primaryOutcome":{"measure":"Local Catheter Site Infection (LCSI)","timeFrame":"study completion","effectByArm":[{"arm":"Omiganan 1% Gel","deltaMin":50,"sd":null},{"arm":"Povidone-Iodine","deltaMin":70,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.082"}]},"eligibility":{"minAge":"13 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":10},"locations":{"siteCount":57,"countries":["United States","France","Germany","Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":null,"commonTop":[]}}